ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,004Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 439

$906K Total Retail Price of All Prescriptions

Rank: 12 out of 439

492 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

35% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 11,460 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 786 426 S3 1 1
LISINOPRIL 656 410 2 4
ATENOLOL 544 324 3 24
AMLODIPINE BESYLATE 484 326 4 2
FUROSEMIDE 465 327 5 5
CLONIDINE HCL 390 192 6 47
LEVOTHYROXINE SODIUM 353 295 7 9
SIMVASTATIN 349 231 8 3
WARFARIN SODIUM 333 284 9 10
POTASSIUM CHLORIDE 314 241 10 30
METOPROLOL TARTRATE 288 229 11 11
OMEPRAZOLE 280 192 12 6
TAMSULOSIN HCL 270 199 13 15
METFORMIN HCL 269 158 14 29
PRAVASTATIN SODIUM 262 141 15 23
CLOPIDOGREL 258 182 16 16
GLIMEPIRIDE 251 153 17 61
NEXIUM 243 170 18 32
ZOLPIDEM TARTRATE 234 66 19 14
RANITIDINE HCL 226 113 20 39
PLAVIX 204 133 21 26
GABAPENTIN 186 99 22 7
ALLOPURINOL 176 127 23 54
CRESTOR 175 105 24 33
INSULIN SYRINGE 174 81 25 78
CITALOPRAM HBR 168 101 26 34
TRAMADOL HCL 163 130 27 21
DONEPEZIL HCL 161 135 28 22
CARVEDILOL 160 109 29 8
PREDNISONE 159 109 30 17
MELOXICAM 151 117 31 40
DIGOXIN 146 129 32 38
SERTRALINE HCL 141 71 33 44
ZETIA 139 108 34 99
PROMETHAZINE HCL 136 46 R 35 68
CEPHALEXIN 133 88 36 98
ROPINIROLE HCL 132 65 37 80
ATORVASTATIN CALCIUM 130 95 38 12
METOPROLOL SUCCINATE 128 76 39 13
NOVOLIN 70-30 118 35 40 269
CYCLOBENZAPRINE HCL 117 49 R 41 49
MIRTAZAPINE 116 78 42 92
POLYETHYLENE GLYCOL 3350 115 72 43 126
CIPROFLOXACIN HCL 115 78 43 41
HYDROCHLOROTHIAZIDE 108 76 45 18
SINGULAIR 102 73 46 139
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 65 47 96
RAMIPRIL 91 60 47 118
FAMOTIDINE 91 60 47 69
BYSTOLIC 90 56 50 223
NAMENDA 90 78 50 20
HYDRALAZINE HCL 90 60 50 55
CYMBALTA 89 42 53 45
KLOR-CON 10 88 71 54 179
AZITHROMYCIN 88 51 54 79
LYRICA 88 39 54 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 36 57 63
LANTUS 84 50 58 85
CARISOPRODOL 83 26 R 59 19
QUETIAPINE FUMARATE 80 68 60 52
NIFEDIPINE ER 78 66 61 83
AMITRIPTYLINE HCL 77 49 R 62 71
TRAZODONE HCL 74 50 63 35
AMLODIPINE BESYLATE-BENAZEPRIL 74 58 63 162
GLIPIZIDE 72 43 65 120
DILTIAZEM HCL 72 31 65 333
PRAMIPEXOLE DIHYDROCHLORIDE 72 49 65 165
ISOSORBIDE MONONITRATE ER 71 61 68 28
ADVAIR DISKUS 69 42 69 36
PAROXETINE HCL 63 42 70 146
HYDROXYZINE HCL 62 49 R 71 290
COMBIVENT 62 14 71 153
COLCRYS 62 38 71 201
HUMULIN 70-30 59 27 74 279
BENAZEPRIL HCL 59 41 74 130
ESCITALOPRAM OXALATE 56 40 76 123
NOVOLIN R 56 33 76 314
DIOVAN HCT 54 36 78 128
LOVASTATIN 54 54 78 103
LOSARTAN POTASSIUM 53 35 80 31
JANUVIA 53 37 80 113
FLUTICASONE PROPIONATE 51 23 82 50
ALPRAZOLAM 51 49 82 216
OXYCODONE HCL-ACETAMINOPHEN 50 14 S2 84 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.